Literature DB >> 12363423

Use of hearing aids in the management of children with cleft palate.

A A Maheshwar1, M A P Milling, M Kumar, M I Clayton, A Thomas.   

Abstract

OBJECTIVE: The incidence of otitis media with effusion in children with cleft palate is high. There are numerous reports looking at early insertion of ventilation tubes (VT) with associated complications. We believe that this is the first paper that discusses the use of hearing aids (HA) as the first line of management.
METHODS: Children with cleft palate are managed in a special multidisciplinary clinic in our hospital. Detailed records of these children are maintained. We studied the otological management of 70 children with repaired cleft palate.
RESULTS: 12 of the 70 (17.1%) had VT inserted, 17 (24.3%) were provided with HA, 14 (20%) had both grommets and HA and 27 (38.6%) had neither. Of the 31 (44.3%) children who had HA, 16 (51.6%) had good compliance with the HA. The hearing, speech and language developments in these children have been good. Twelve of the 70 patients (17.1%) have had one or more otological complications. These were significantly higher in children treated with VT.
CONCLUSION: We have successfully treated 62.9% of our patients with non-surgical intervention, and show a low incidence of long term complications.

Entities:  

Mesh:

Year:  2002        PMID: 12363423     DOI: 10.1016/s0165-5876(02)00206-9

Source DB:  PubMed          Journal:  Int J Pediatr Otorhinolaryngol        ISSN: 0165-5876            Impact factor:   1.675


  9 in total

1.  The incidence of secretory otitis media in cases of cleft palate.

Authors:  D Sridhara Narayanan; S Sundara Pandian; S Murugesan; Ramya Kumar
Journal:  J Clin Diagn Res       Date:  2013-07-01

2.  A model-based cost-effectiveness analysis of a grommets-led care pathway for children with cleft palate affected by otitis media with effusion.

Authors:  Syed Mohiuddin; Katherine Payne; Elisabeth Fenwick; Kevin O'Brien; Iain Bruce
Journal:  Eur J Health Econ       Date:  2014-06-07

3.  [Otological findings in adults with isolated cleft palate or cleft lip, jaw, and palate].

Authors:  V Gudziol; W J Mann
Journal:  Mund Kiefer Gesichtschir       Date:  2004-10-21

4.  A review of hearing loss in cleft palate patients.

Authors:  Bilal Gani; A J Kinshuck; R Sharma
Journal:  Int J Otolaryngol       Date:  2012-02-12

5.  The Importance of Integration of Stakeholder Views in Core Outcome Set Development: Otitis Media with Effusion in Children with Cleft Palate.

Authors:  Nicola L Harman; Iain A Bruce; Jamie J Kirkham; Stephanie Tierney; Peter Callery; Kevin O'Brien; Alex M D Bennett; Raouf Chorbachi; Per N Hall; Anne Harding-Bell; Victoria H Parfect; Nichola Rumsey; Debbie Sell; Ravi Sharma; Paula R Williamson
Journal:  PLoS One       Date:  2015-06-26       Impact factor: 3.240

6.  Economic evaluation of surgical insertion of ventilation tubes for the management of persistent bilateral otitis media with effusion in children.

Authors:  Syed Mohiuddin; Anne Schilder; Iain Bruce
Journal:  BMC Health Serv Res       Date:  2014-06-13       Impact factor: 2.655

Review 7.  Updates and knowledge gaps in cholesteatoma research.

Authors:  Chin-Lung Kuo; An-Suey Shiao; Matthew Yung; Masafumi Sakagami; Holger Sudhoff; Chih-Hung Wang; Chyong-Hsin Hsu; Chiang-Feng Lien
Journal:  Biomed Res Int       Date:  2015-03-18       Impact factor: 3.411

8.  MOMENT--Management of Otitis Media with Effusion in Cleft Palate: protocol for a systematic review of the literature and identification of a core outcome set using a Delphi survey.

Authors:  Nicola L Harman; Iain A Bruce; Peter Callery; Stephanie Tierney; Mohammad Owaise Sharif; Kevin O'Brien; Paula R Williamson
Journal:  Trials       Date:  2013-03-12       Impact factor: 2.279

9.  Profile of patients with cleft palate fitted with hearing AIDS.

Authors:  Ticiana Cristina de Freitas Zambonato; Mariza Ribeiro Feniman; Wanderléia Quinhoneiro Blasca; José Roberto Pereira Lauris; Luciana Paula Maximino
Journal:  Braz J Otorhinolaryngol       Date:  2009 Nov-Dec
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.